| ¿µ¹® | oral administration | ÇÑ±Û | °æ±¸º¹¿ë |
|---|---|---|---|
| ¼³¸í | ¾àÀ» Åõ¿©ÇÏ´Â ¹æ¹ý¿¡´Â ¿©·¯ °¡Áö°¡ ÀÖ´Ù. Å©°Ô ³ª´©¾î º¸¸é, ÀÔÀ» °ÅÃÄ À§Ã¢Àڰ踦 ÅëÇØ ³Ö´Â ¹æ¹ý°ú À§Ã¢Àڰ踦 ÅëÇÏÁö ¾Ê°í ¹Ù·Î Ç÷¾×À¸·Î ³Ö´Â ¹æ¹ýÀÌ ÀÖ´Ù. À§Ã¢Àڰ踦 ÅëÇÏÁö ¾Ê´Â ¹æ¹ýÀ¸·Î °¡Àå ÈçÇÑ ¹æ¹ýÀº Áֻ縦 ÀÌ¿ëÇÏ´Â ¹æ¹ýÀÌ´Ù. ÇÏÁö¸¸, À̿ܿ¡ Ç×¹®À» ÅëÇØ ³Ö´Â Á¾à½Ä¹æ¹ý°ú Çô¹Ø¿¡ ³Ö´Â Çô¹ØÅõ¿©¹ýµµ ÀÖ´Ù. ±×·¯³ª ´ëºÎºÐÀÇ ¾àÁ¦´Â °æ±¸º¹¿ëÀ» ÇÏ°Ô µÈ´Ù. °æ±¸º¹¿ë¿¡ ´ëÇÑ ¾àÀÚ´Â p.o.(per oral)·Î Ç¥±âÇÑ´Ù. °æ±¸º¹¿ëÁ¦ÀÇ ´ÜÁ¡Àº º¹¿ëÇÑ ¾àÁ¦°¡ À§Ã¢ÀÚ°ü°è¸¦ °ÅÄ¡¸é¼ »ç¶÷¸¶´Ù °¢±â ´Ù¸¥ Èí¼öÁ¤µµ¿Í ´ë»çÁ¤µµ¸¦ °ÅÄ¡°Ô µÇ¹Ç·Î ÀÏÁ¤ÇÑ ³óµµÀ¯Áö°¡ ¾î·Æ´Ù´Âµ¥ ÀÖ´Ù. ¶ÇÇÑ °æ±¸º¹¿ëÁ¦ÀÇ ¸ð¾çÀÌ Ä¸½¶ÇüÀÎÁö, ȤÀº °¡·çÇüÀÎÁö¿¡ µû¶ó¼µµ °°Àº ¾àÀÌÁö¸¸, ¼·Î ´Ù¸¥ È¿°ú¸¦ ³ªÅ¸³¾ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | oral cavity | ÇÑ±Û | ±¸° |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ¹ú¿©¼ ÀÔ¼Ó¿¡¼ º¼ ¼ö ÀÖ´Â °ø°£À¸·Î ÀÔõÀå, Æíµµ, ¸ñÁ¥À» º¼ ¼ö ÀÖ´Ù. ![]() |
||
| ¿µ¹® | oral cavity | ÇÑ±Û | ÀÔ¾È |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ¹ú¿©¼ ÀÔ¼Ó¿¡¼ º¼ ¼ö ÀÖ´Â °ø°£À¸·Î ÀÔõÀå, Æíµµ, ¸ñÁ¥À» º¼ ¼ö ÀÖ´Ù. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| OCP | octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil... |
| OET | oral endotracheal tube; oral esophageal tube |
| OHI | Occupational Health Institute; operative hypertension indicator; oral hygiene index; Oral Hygiene In... |
| E2 | 17b-estradiol |
| 17 beta-E(2) | 17 beta-estradiol |
|---|---|
| EE | 17-alpha-ethinyl estradiol |
| E2 | 17-beta-Estradiol |
| E | 17-beta-estradiol |
| EE2 | 17alpha-ethinyl estradiol |
naso-oral
| acyl-CoA-estradiol-17-beta-acyltransferase | <enzyme> Catalyses the esterification of estradiol with long chain fatty acids at the 17-position Registry number: EC 2.3.1.- Synonym: acylcoenzyme a-estradiol-17-beta-acyltransferase, estradiol 17-acyltransferase (26 Jun 1999) |
|---|---|
| receptors, estradiol | Cytoplasmic proteins that bind estradiol, migrate to the nucleus, and regulate DNA transcription. (12 Dec 1998) |
| estradiol | A hormone (272 D) synthesised mainly in the ovary, but also in the placenta, testis and possibly adrenal cortex. A potent oestrogen. (18 Nov 1997) |
| estradiol 15 alpha-hydroxylase | <enzyme> Catalyses the conversion of estradiol to 15alpha-hydroxyestradiol Registry number: EC 1.14.99.- Synonym: e15a-hydroxylase (26 Jun 1999) |
| estradiol 16 alpha-hydroxylase | <enzyme> Cyp2c11 is a male-specific cyp isoform Registry number: EC 1.14.99.- Synonym: 16 alpha-hydroxylase, estrone 16 alpha-hydroxylase, 16alpha-hydroxylase, steroid 16 alpha-hydroxylase, estrone 3-sulfate 16 alpha-hydroxylase, cytochrome p450cmf, cytochrome p450 2c, cytochrome p450iic11, cytochrome p450(ut-a), cytochrome p4502c-rml5, cytochrome p450h, cytochrome p450(male), cytochrome p4502c, cytochrome p450 2c3, cytochrome p450 2c9, oestrogen 16-hydroxylase, cyp2c3 gene product, cyp2c11 gene product, cytochrome p450 2c11, cyp 2d-9, cytochrome p450(tb), cyp2c9, cytochrome p-450(m1), cyp2c11 (26 Jun 1999) |
| estradiol-17 beta sulfotransferase | <enzyme> Specific for estradiol 17beta; not the same as EC 2.8.2.15 Registry number: EC 2.8.2.- (26 Jun 1999) |
| estradiol antagonists | Compounds which inhibit or antagonise the biosynthesis or action of estradiol. (12 Dec 1998) |
| estradiol benzoate unit | The oestrogenic activity of 0.1 ug of a standard preparation of estradiol benzoate. (05 Mar 2000) |
| estradiol dehydrogenases | <enzyme> Enzymes that catalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration.2 Chemical name: Estradiol-17 beta:NAD(P)+ 17-oxidoreductase Registry number: EC 1.1.1.62 (12 Dec 1998) |
| estradiol receptor tyrosine kinase | <enzyme> Calcium and calmodulin dependent Registry number: EC 2.7.1.- Synonym: ertk (26 Jun 1999) |
| ethinyl estradiol | <chemical> (17 alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol. A semisynthetic oestrogen with high oral oestrogenic potency. It is often used as the oestrogenic component in oral contraceptives. Pharmacological action: antineoplastic agent, hormonal, oestrogens, synthetic. Chemical name: 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)- (12 Dec 1998) |
| ethinyl estradiol-norgestrel combination | <chemical> Ethinyl estradiol and norgestrel given in fixed proportions. It has proved to be an effective contraceptive. Pharmacological action: contraceptives, oral, combined, contraceptives, oral, synthetic, contraceptives, postcoital, synthetic. (12 Dec 1998) |
| ethynyl estradiol | 17a-ethynyl-1,3,5-estratriene-3,17-diol;a semisynthetic derivative of 17b-estradiol; active by mouth, with a long half-life, it is among the most potent of known oestrogenic compounds; used in oral contraceptive preparations. Synonym: ethinyl estradiol. Estradiol undecylate, an esterified natural oestrogen for parenteral use. Estradiol valerate, estra-1,3,5(10)-triene-3,17b-diol 17-valerate;same actions and uses as estradiol, but with a prolonged duration of action; administered in sesame oil by intramuscular injection. (05 Mar 2000) |
| administration, oral | The giving of drugs, chemicals, or other substances by mouth. (12 Dec 1998) |
| cancer, oral | Cancer of the mouth area. A sore in the mouth that does not heal can be a warning sign of oral cancer. A biopsy is the only to know whether as abnormal area in the oral cavity is cancer. Oral cancer is caused by tobacco (smoking and chewing) and alcohol use. Surgery to remove the tumour in the mouth is the usual treatment for patients with oral cancer. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|